ES8704082A1 - Procedimiento para preparar un agente terapeutico a base de celulas tumorales humanas y eventualmente, neuraminidasa. - Google Patents
Procedimiento para preparar un agente terapeutico a base de celulas tumorales humanas y eventualmente, neuraminidasa.Info
- Publication number
- ES8704082A1 ES8704082A1 ES546701A ES546701A ES8704082A1 ES 8704082 A1 ES8704082 A1 ES 8704082A1 ES 546701 A ES546701 A ES 546701A ES 546701 A ES546701 A ES 546701A ES 8704082 A1 ES8704082 A1 ES 8704082A1
- Authority
- ES
- Spain
- Prior art keywords
- therapeutic agent
- preparation
- tumour therapeutic
- monoclonal antibodies
- antigens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 229940124597 therapeutic agent Drugs 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 102000005348 Neuraminidase Human genes 0.000 abstract 1
- 108010006232 Neuraminidase Proteins 0.000 abstract 1
- 210000005260 human cell Anatomy 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Window Of Vehicle (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
METODO DE PREPARACION DE COMPOSICIONES A BASE DE CELULAS TUMORALES HUMANAS. COMPRENDE LA PREPARACION DE UNA SUSPENSION ACUOSA ISOTONICA DE CELULAS TUMORALES HUMANAS QUE LLEVAN UN ANTIGENO FIJADO POR UN ANTICUERPO MONOCLONAL, CON PROPIEDADES INMUNOLOGICAS ESPECIFICAS, QUE CONTIENE UNA SUSTANCIA REGULADORA DE PH A VALOS ENTRE 6 Y 8, NO TOXICA; ELIMINACION DEL AGUA POR CONGELACION A TEMPERATURA INFERIOR A 0JC Y EVAPORACION DEL AGUA A PRESION REDUCIDA; Y TRATAMIENTO DE LAS CELULAS SECAS CON EL MISMO VOLUMEN DE AGUA EN EL QUE ANTES ESTABAN SUSPENDIDAS. ESTAS SUSPENSIONES TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE ENFERMEDADES TUMORALES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19843432714 DE3432714A1 (de) | 1984-09-06 | 1984-09-06 | Tumortherapeutikum und verfahren zu seiner herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8704082A1 true ES8704082A1 (es) | 1987-03-16 |
ES546701A0 ES546701A0 (es) | 1987-03-16 |
Family
ID=6244749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES546701A Expired ES8704082A1 (es) | 1984-09-06 | 1985-09-04 | Procedimiento para preparar un agente terapeutico a base de celulas tumorales humanas y eventualmente, neuraminidasa. |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0173951B1 (es) |
JP (1) | JPS6168427A (es) |
AT (1) | ATE64531T1 (es) |
CA (1) | CA1277600C (es) |
DE (2) | DE3432714A1 (es) |
DK (1) | DK172253B1 (es) |
ES (1) | ES8704082A1 (es) |
FI (1) | FI88360C (es) |
GR (1) | GR852149B (es) |
IE (1) | IE58638B1 (es) |
IL (1) | IL76289A (es) |
PT (1) | PT81093B (es) |
ZA (1) | ZA856807B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3806565A1 (de) * | 1988-03-01 | 1989-09-14 | Deutsches Krebsforsch | Virusmodifizierte tumorvakzinen fuer die immuntherapie von tumormetastasen |
AT398900B (de) * | 1991-02-12 | 1995-02-27 | Pekar Rudolf Dr | Vakzine für eine immuntherapie |
US7070782B1 (en) | 1992-11-05 | 2006-07-04 | Sloan-Kettering Institute For Cancer Research | Prostate-specific membrane antigen |
US6953668B1 (en) | 1992-11-05 | 2005-10-11 | Sloan-Kettering Institute For Cancer Research | Prostate-specific membrane antigen |
US7105159B1 (en) | 1992-11-05 | 2006-09-12 | Sloan-Kettering Institute For Cancer Research | Antibodies to prostate-specific membrane antigen |
JP4204642B2 (ja) * | 1992-11-05 | 2009-01-07 | スローン − ケタリング・インスティテュート・フォー・キャンサー・リサーチ | 前立腺に特異的な膜抗原 |
US6569432B1 (en) | 1995-02-24 | 2003-05-27 | Sloan-Kettering Institute For Cancer Research | Prostate-specific membrane antigen and uses thereof |
US7037647B1 (en) | 1995-02-24 | 2006-05-02 | Sloan-Kettering Institute For Cancer Research | Prostate-specific membrane antigen and uses thereof |
DE19506483A1 (de) * | 1995-02-24 | 1996-08-29 | Jens Dr Dr Atzpodien | Lyophilisat-Vakzine |
US20050215472A1 (en) | 2001-10-23 | 2005-09-29 | Psma Development Company, Llc | PSMA formulations and uses thereof |
EP2360169B1 (en) | 2001-10-23 | 2015-10-14 | Psma Development Company, L.L.C. | PSMA antibodies |
CN1315536C (zh) * | 2002-09-13 | 2007-05-16 | 李进 | 肿瘤抗原疫苗及其制备方法和疫苗组合物 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4152410A (en) * | 1975-09-03 | 1979-05-01 | Eisai Co., Ltd. | Diagnosis reagent for neoplasm and method for diagnosis of neoplasm |
DE2643215A1 (de) * | 1976-09-25 | 1978-04-06 | Bayer Ag | Cancerostatisch wirksame praeparationen aus tumorzellen und ein verfahren zu ihrer herstellung |
ZA776822B (en) * | 1976-11-24 | 1979-06-27 | D Mccollester | Vaccine and method for immunotherapy of neoplastic disease |
DE2918927A1 (de) * | 1979-05-10 | 1980-11-20 | Hans Prof Dr Limburg | Arzneipraeparat zur behandlung von carcinomen und verfahren zu dessen herstellung |
US4446122A (en) * | 1979-12-28 | 1984-05-01 | Research Corporation | Purified human prostate antigen |
US4468457A (en) * | 1981-06-01 | 1984-08-28 | David M. Goldenberg | Method for producing a CSAp tryptic peptide and anti-CSAp antibodies |
DE3416774A1 (de) * | 1984-05-07 | 1985-11-14 | Behringwerke Ag, 3550 Marburg | Monoklonale antikoerper, verfahren zu ihrer herstellung sowie ihre verwendung |
DE3329184A1 (de) * | 1983-08-12 | 1985-02-21 | Behringwerke Ag, 3550 Marburg | Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene |
-
1984
- 1984-09-06 DE DE19843432714 patent/DE3432714A1/de not_active Withdrawn
-
1985
- 1985-08-27 DE DE8585110757T patent/DE3583265D1/de not_active Expired - Fee Related
- 1985-08-27 EP EP85110757A patent/EP0173951B1/de not_active Expired - Lifetime
- 1985-08-27 AT AT85110757T patent/ATE64531T1/de not_active IP Right Cessation
- 1985-09-03 DK DK402485A patent/DK172253B1/da not_active IP Right Cessation
- 1985-09-04 IL IL76289A patent/IL76289A/xx not_active IP Right Cessation
- 1985-09-04 ES ES546701A patent/ES8704082A1/es not_active Expired
- 1985-09-04 GR GR852149A patent/GR852149B/el unknown
- 1985-09-04 FI FI853389A patent/FI88360C/fi not_active IP Right Cessation
- 1985-09-05 JP JP60195000A patent/JPS6168427A/ja active Pending
- 1985-09-05 IE IE219185A patent/IE58638B1/en not_active IP Right Cessation
- 1985-09-05 PT PT81093A patent/PT81093B/pt not_active IP Right Cessation
- 1985-09-05 CA CA000490026A patent/CA1277600C/en not_active Expired - Lifetime
- 1985-09-05 ZA ZA856807A patent/ZA856807B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DE3432714A1 (de) | 1986-04-24 |
ZA856807B (en) | 1986-04-30 |
EP0173951A3 (en) | 1988-06-08 |
IL76289A (en) | 1992-01-15 |
IE852191L (en) | 1986-03-06 |
FI88360B (fi) | 1993-01-29 |
ATE64531T1 (de) | 1991-07-15 |
CA1277600C (en) | 1990-12-11 |
EP0173951B1 (de) | 1991-06-19 |
PT81093B (pt) | 1988-07-01 |
IL76289A0 (en) | 1986-01-31 |
EP0173951A2 (de) | 1986-03-12 |
DK172253B1 (da) | 1998-02-09 |
FI853389A0 (fi) | 1985-09-04 |
DE3583265D1 (de) | 1991-07-25 |
IE58638B1 (en) | 1993-10-20 |
DK402485D0 (da) | 1985-09-03 |
GR852149B (es) | 1986-01-03 |
DK402485A (da) | 1986-03-07 |
ES546701A0 (es) | 1987-03-16 |
PT81093A (de) | 1985-10-01 |
JPS6168427A (ja) | 1986-04-08 |
FI853389L (fi) | 1986-03-07 |
FI88360C (fi) | 1993-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL67721A (en) | Hybridoma cell lines,their preparation and their use for the production of human monoclonal antibodies | |
DE3269625D1 (en) | Benzazepin-2-ones, process for their preparation, pharmaceutical preparations containing these compounds and the compounds for therapeutical use | |
EP0260610A3 (en) | Monoclonal antibodies against human tumour necrotic factor (tnf), and their use | |
WO1994029351A3 (en) | Antibodies | |
GB2102810B (en) | Human interferon-related peptides antigens antibodies and process for preparing the same | |
IL90990A0 (en) | Pharmaceutical and diagnostic compositions containing monoclonal antibodies reactive with cachectin and a cell for the production thereof | |
IL76142A (en) | Monoclonal antibody specific to a human carcinoma tumor-associated antigen kc-4,hybrid cell lines producing the same,pharmaceutical compositions containing them and methods for the use thereof | |
TW376320B (en) | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma | |
EP0161606A3 (en) | Drug, and methods of preparing and using it for treatment of tumors | |
HUT41836A (en) | Process for preparing monoclonal antibodies cross-reactive and cross-protecting against p. aeruginosa serotypes | |
ES8704082A1 (es) | Procedimiento para preparar un agente terapeutico a base de celulas tumorales humanas y eventualmente, neuraminidasa. | |
DE3163162D1 (en) | Platinum-isocitrate complex, process for its preparation and its therapeutical application | |
ZA897858B (en) | Family of high affinity,modified antibodies for cancer treatment | |
HUT38391A (en) | Process for preparing new monoclonal antibodies against glycoconjugates and for the utilization thereof | |
CA2192079A1 (en) | Human Monoclonal Antibodies Specific to Cell Cycle Independent Glioma Surface Antigen | |
EP0198086A4 (en) | MAN-MOUSE HYBRIDOMA PRODUCING HUMAN ANTIVIRAL ANTIBODY, PREPARATION METHOD AND HUMAN ANTIVIRAL MONOCLONAL ANTIBODY. | |
EP0194851A3 (en) | Human tumor therapy | |
IL70968A (en) | Urea-linked immunogens,their preparation and antibodies thereto | |
ZA837857B (en) | Platinum-diamine complexes,a process for the preparation thereof and a process for the preparation of a medical composition using such a complex for the treatment of cancer | |
EP0203967A4 (en) | SPECIFIC ONCO-FETAL MONOCLONAL ANTIBODIES, METHODS OF PREPARATION AND USE. | |
HUT36783A (en) | Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane | |
EP0306680A3 (en) | Monoclonal antibodies to anti-thrombin binding substance, and their uses | |
EP0166458A3 (en) | Monoclonal antibody capable of specifically distinguishing human hepato-carcinoma cells | |
EP0307476A4 (en) | Bilirubin antigen, monoclonal antibody therefor, process for their preparation, and their use | |
GB2048069B (en) | Medicinal preparations for treating carcinomas |